Molecular basis of clarithromycin activity against Mycobacterium avium and Mycobacterium smegmatis

The Journal of Antimicrobial Chemotherapy
Florence Doucet-PopulaireRobert C Goldman

Abstract

Clarithromycin, the 6-O-methyl derivative of erythromycin, is approved for treatment of Mycobacterium avium infections and for prophylaxis in patients at risk. Since clarithromycin is more active against mycobacteria than the parent compound, erythromycin, we evaluated the interaction of erythromycin and clarithromycin with cells and ribosomes isolated from M. avium and Mycobacterium smegmatis. The MIC of clarithromycin was 32 and 64 times lower than that of erythromycin for M. smegmatis and M. avium, respectively. The cellular uptake rate for clarithromycin was two- to five-fold faster than for erythromycin, and cell-associated clarithromycin reached a plateau two-fold higher than that of erythromycin after 3 h. Energy was not required for uptake. Fractionation of cell-associated clarithromycin yielded 12% in the walls, 21% bound to ribosomes, with the remainder being lost during work-up. In addition, three- to six-fold more clarithromycin was associated with the isolated cell integument compared with erythromycin. The Kd for clarithromycin binding to ribosomes was 2.9- and 3.5-fold tighter for M. smegmatis and M. avium, respectively, than for erythromycin, due mainly to a slower off-rate. The log partition coefficients of the...Continue Reading

Citations

Dec 10, 2003·Plastic and Reconstructive Surgery·Raymond S DouglasNorman Shorr
Mar 29, 2005·Antimicrobial Agents and Chemotherapy·Kanakeshwari FalzariScott G Franzblau
Jul 6, 2012·Clinical Microbiology Reviews·Barbara A Brown-ElliottRichard J Wallace
Nov 10, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Junjie ZhangHongmin Zhang
Oct 10, 2008·Tuberculosis·Zhaohai J ZhuScott G Franzblau
Mar 18, 2008·Journal of Molecular Biology·S V S R K PulavartiAshish Arora
Oct 20, 2001·Ophthalmic Plastic and Reconstructive Surgery·F Gonzalez-Fernandez, S A Kaltreider
Aug 16, 2003·Ophthalmic Plastic and Reconstructive Surgery·Joseph A Mauriello, UNKNOWN Atypical Mycobacterial Study Group
Jul 1, 2017·British Journal of Pharmacology·George P Dinos
Oct 18, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hongzhi XiaoXingyuan Cao
Feb 11, 2005·Chemical Reviews·Leonard Katz, Gary W Ashley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.